RIMIFON Drug Patent Profile
✉ Email this page to a colleague
When do Rimifon patents expire, and what generic alternatives are available?
Rimifon is a drug marketed by Roche and is included in one NDA.
The generic ingredient in RIMIFON is isoniazid. There are five drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the isoniazid profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Rimifon
A generic version of RIMIFON was approved as isoniazid by OMNIVIUM PHARMS on June 26th, 1997.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RIMIFON?
- What are the global sales for RIMIFON?
- What is Average Wholesale Price for RIMIFON?
Summary for RIMIFON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 154 |
| Clinical Trials: | 1 |
| Patent Applications: | 4,101 |
| DailyMed Link: | RIMIFON at DailyMed |
Recent Clinical Trials for RIMIFON
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Assistance Publique - Hôpitaux de Paris | Phase 2 |
US Patents and Regulatory Information for RIMIFON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roche | RIMIFON | isoniazid | INJECTABLE;INJECTION | 008420-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roche | RIMIFON | isoniazid | INJECTABLE;INJECTION | 008420-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Roche | RIMIFON | isoniazid | SYRUP;ORAL | 008420-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
